CEFIXIME
Generic: CEFIXIME
Aurobindo Pharma LimitedManufacturer
ORALRoute
CEFIXIMEActive Substance
2026-03-23Original Approval
CEFIXIME is FDA application ANDA217607, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2024-05-30
Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: LFailed Content Uniformity Specifications
Class II2021-12-21
Cefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, India, DistributFailed impurities/degradation specifications
Class II2021-04-29
Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. BaSubpotent Drug
Class II2020-04-15
Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 2Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.
Class II2021-11-03
Cefixime Capsules 400 mg, 50 capsules bottles, Rx Only, Manufactured by: Alken Laboratories Ltd., Mumbai - 400 013, IndiFailed Impurities/Degradation Specifications
Class II2024-01-03
Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore,Failed Impurities/Degradation Specifications
Class II2024-08-21
Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., BalSubpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long t
Top Reported Reactions
1
OFF LABEL USE
299 reports
2
DRUG INEFFECTIVE
292 reports
3
PYREXIA
175 reports
4
DIARRHOEA
174 reports
5
NAUSEA
173 reports
6
PAIN
158 reports
7
MALAISE
141 reports
8
FATIGUE
138 reports
9
HEADACHE
136 reports
10
VOMITING
136 reports